Disease related changes in ATAC-Seq of more than 450 iPSC-derived motor neuron lines from ALS patients and controls
暂无分享,去创建一个
Velina Kozareva | Susan Lei | D. Sareen | Ernest Fraenkel | Stanislav Tsitkov | Kelsey Valentine | Aneesh Donde | Aaron Frank | Jennifer Van Eyk | Steve Finkbeiner | Jeffrey Rothstein | Leslie M. Thompson | Clive N. Svendsen | E. Fraenkel | Jeffrey D. Rothstein
[1] E. Fraenkel,et al. Large-scale differentiation of iPSC-derived motor neurons from ALS and control subjects , 2023, Neuron.
[2] D. Hernandez,et al. The Foundational Data Initiative for Parkinson Disease: Enabling efficient translation from genetic maps to mechanism , 2023, Cell genomics.
[3] Yen-Chung Chen,et al. Single-cell transcriptomic analysis reveals diversity within mammalian spinal motor neurons , 2023, Nature Communications.
[4] Y. Pawitan,et al. T cell responses at diagnosis of amyotrophic lateral sclerosis predict disease progression , 2022, Nature Communications.
[5] Guanchao Wang,et al. Targeting epigenetics as a promising therapeutic strategy for treatment of neurodegenerative diseases. , 2022, Biochemical pharmacology.
[6] S. Finkbeiner,et al. Huntington’s disease iPSC models—using human patient cells to understand the pathology caused by expanded CAG repeats , 2022, Faculty reviews.
[7] N. Maragakis,et al. Exploring Motor Neuron Diseases Using iPSC Platforms. , 2022, Stem Cells.
[8] Stephen A. Goutman,et al. Recent advances in the diagnosis and prognosis of amyotrophic lateral sclerosis , 2022, The Lancet Neurology.
[9] M. Nalls,et al. Identifying and predicting amyotrophic lateral sclerosis clinical subgroups: a population-based machine-learning study. , 2022, The Lancet. Digital health.
[10] V. Meininger,et al. Neurofilament light and heterogeneity of disease progression in amyotrophic lateral sclerosis: development and validation of a prediction model to improve interventional trials , 2021, Translational neurodegeneration.
[11] S. Haggarty,et al. ELAVL4, splicing, and glutamatergic dysfunction precede neuron loss in MAPT mutation cerebral organoids , 2021, Cell.
[12] G. Bourque,et al. Application of ATAC-Seq for genome-wide analysis of the chromatin state at single myofiber resolution , 2021, bioRxiv.
[13] P. Scheltens,et al. Early life involvement in C9orf72 repeat expansion carriers , 2021, Journal of Neurology, Neurosurgery, and Psychiatry.
[14] B. McCabe,et al. The Links between ALS and NF-κB , 2021, International journal of molecular sciences.
[15] A. Singleton,et al. Tackling neurodegenerative diseases with genomic engineering: A new stem cell initiative from the NIH , 2021, Neuron.
[16] Joanna Sobocińska,et al. KRAB-ZFP Transcriptional Regulators Acting as Oncogenes and Tumor Suppressors: An Overview , 2021, International journal of molecular sciences.
[17] Patricia A. Castruita,et al. p53 is a central regulator driving neurodegeneration caused by C9orf72 poly(PR) , 2021, Cell.
[18] Thomas M. Keane,et al. Twelve years of SAMtools and BCFtools , 2020, GigaScience.
[19] Marco Piñón,et al. I Overview , 2020, The Diaries and Letters of Lord Woolton 1940-1945.
[20] Timothy A. Miller,et al. An integrated multi-omic analysis of iPSC-derived motor neurons from C9ORF72 ALS patients , 2020, bioRxiv.
[21] Andrea D Matlock,et al. Answer ALS, a large-scale resource for sporadic and familial ALS combining clinical and multi-omics data from induced pluripotent cell lines , 2020, Nature Neuroscience.
[22] L. Bosch,et al. Opportunities for histone deacetylase inhibition in amyotrophic lateral sclerosis , 2020, British journal of pharmacology.
[23] B. Treutlein,et al. Robust detection of undifferentiated iPSC among differentiated cells , 2020, Scientific Reports.
[24] M. Hagiwara,et al. Integrated DNA methylation analysis reveals a potential role for ANKRD30B in Williams syndrome , 2020, Neuropsychopharmacology.
[25] O. Stegle,et al. Erosion of human X chromosome inactivation causes major remodeling of the iPSC proteome , 2020, bioRxiv.
[26] O. Hardiman,et al. Lifetime Risk and Heritability of Amyotrophic Lateral Sclerosis. , 2019, JAMA neurology.
[27] S. Haggarty,et al. A Comprehensive Resource for Induced Pluripotent Stem Cells from Patients with Primary Tauopathies , 2019, Stem cell reports.
[28] E. Gamazon,et al. Hepatocyte gene expression and DNA methylation as ancestry-dependent mechanisms in African Americans , 2019, npj Genomic Medicine.
[29] J. Fak,et al. A Large Panel of Isogenic APP and PSEN1 Mutant Human iPSC Neurons Reveals Shared Endosomal Abnormalities Mediated by APP β-CTFs, Not Aβ , 2019, Neuron.
[30] J. Banchereau,et al. Sexual-dimorphism in human immune system aging , 2019, Nature Communications.
[31] Mariana P. Torrente,et al. The impact of histone post-translational modifications in neurodegenerative diseases. , 2019, Biochimica et biophysica acta. Molecular basis of disease.
[32] K. Plath,et al. The Role of Xist in X-Chromosome Dosage Compensation. , 2018, Trends in cell biology.
[33] G. Bourque,et al. Personalized and graph genomes reveal missing signal in epigenomic data , 2020, Genome Biology.
[34] J. Kleinman,et al. Integrated DNA methylation and gene expression profiling across multiple brain regions implicate novel genes in Alzheimer’s disease , 2018, bioRxiv.
[35] Leland McInnes,et al. UMAP: Uniform Manifold Approximation and Projection , 2018, J. Open Source Softw..
[36] H. Okano,et al. Modeling sporadic ALS in iPSC-derived motor neurons identifies a potential therapeutic agent , 2018, Nature Medicine.
[37] H. Okano,et al. Modeling sporadic ALS in iPSC-derived motor neurons identifies a potential therapeutic agent , 2018, Nature Medicine.
[38] Michael J. Cowan,et al. Haploinsufficiency leads to neurodegeneration in C9ORF72 ALS/FTD human induced motor neurons , 2018, Nature Medicine.
[39] B. Dubois,et al. Early Cognitive, Structural, and Microstructural Changes in Presymptomatic C9orf72 Carriers Younger Than 40 Years , 2018, JAMA neurology.
[40] K. Plath,et al. Regulation of X-chromosome dosage compensation in human: mechanisms and model systems , 2017, Philosophical Transactions of the Royal Society B: Biological Sciences.
[41] E. Rogaeva,et al. Dysregulation of chromatin remodelling complexes in amyotrophic lateral sclerosis , 2017, Human molecular genetics.
[42] Helen E. Parkinson,et al. The human-induced pluripotent stem cell initiative—data resources for cellular genetics , 2016, Nucleic Acids Res..
[43] C. López-Otín,et al. iPSCs: On the Road to Reprogramming Aging. , 2016, Trends in molecular medicine.
[44] Eric E. Schadt,et al. variancePartition: interpreting drivers of variation in complex gene expression studies , 2016, BMC Bioinformatics.
[45] H. Okano,et al. Functional Neurons Generated from T Cell-Derived Induced Pluripotent Stem Cells for Neurological Disease Modeling , 2016, Stem Cell Reports.
[46] Yonglun Luo,et al. The Epigenetic Reprogramming Roadmap in Generation of iPSCs from Somatic Cells. , 2015, Journal of genetics and genomics = Yi chuan xue bao.
[47] J. Hell,et al. Imbalance of excitatory/inhibitory synaptic protein expression in iPSC-derived neurons from FOXG1+/− patients and in foxg1+/− mice , 2015, European Journal of Human Genetics.
[48] V. Fossati,et al. Generation and isolation of oligodendrocyte progenitor cells from human pluripotent stem cells , 2015, Nature Protocols.
[49] M. Pellegrini,et al. Pioneer Transcription Factors Target Partial DNA Motifs on Nucleosomes to Initiate Reprogramming , 2015, Cell.
[50] Howard Y. Chang,et al. ATAC‐seq: A Method for Assaying Chromatin Accessibility Genome‐Wide , 2015, Current protocols in molecular biology.
[51] W. Huber,et al. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 , 2014, Genome Biology.
[52] Johann S. Hawe,et al. Crowdsourced analysis of clinical trial data to predict amyotrophic lateral sclerosis progression , 2014, Nature Biotechnology.
[53] Nicolas Stifani,et al. Motor neurons and the generation of spinal motor neuron diversity , 2014, Front. Cell. Neurosci..
[54] Morgan L. Maeder,et al. Pathways disrupted in human ALS motor neurons identified through genetic correction of mutant SOD1. , 2014, Cell stem cell.
[55] Sharon Y. R. Dent,et al. Chromatin modifiers and remodellers: regulators of cellular differentiation , 2013, Nature Reviews Genetics.
[56] D. Krainc,et al. Human iPSC-based modeling of late-onset disease via progerin-induced aging. , 2013, Cell stem cell.
[57] T. Gillis,et al. Induced pluripotent stem cells from patients with Huntington's disease show CAG-repeat-expansion-associated phenotypes. , 2012, Cell stem cell.
[58] K. Eggan,et al. Erosion of dosage compensation impacts human iPSC disease modeling. , 2012, Cell stem cell.
[59] I. Ellis,et al. Differential oestrogen receptor binding is associated with clinical outcome in breast cancer , 2011, Nature.
[60] L. Martin,et al. Epigenetic Regulation of Motor Neuron Cell Death through DNA Methylation , 2011, The Journal of Neuroscience.
[61] S. Lehmann,et al. Rejuvenating senescent and centenarian human cells by reprogramming through the pluripotent state. , 2011, Genes & development.
[62] Martin J. Aryee,et al. Epigenetic memory in induced pluripotent stem cells , 2010, Nature.
[63] C. Glass,et al. Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. , 2010, Molecular cell.
[64] Trevor Hastie,et al. Regularization Paths for Generalized Linear Models via Coordinate Descent. , 2010, Journal of statistical software.
[65] Jian Huang,et al. Identification and functional analysis of a novel human KRAB/C2H2 zinc finger gene ZNF300. , 2004, Biochimica et biophysica acta.
[66] Florian Hahne,et al. Visualizing Genomic Data Using Gviz and Bioconductor , 2016, Statistical Genomics.
[67] A. Ludolph,et al. Amyotrophic lateral sclerosis. , 2012, Current opinion in neurology.
[68] M. Buchfelder,et al. The neurotrophic protein S100B: value as a marker of brain damage and possible therapeutic implications. , 2007, Progress in brain research.